Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge

作者: Takako Takeda , Ming Hao , Tiejun Cheng , Stephen H. Bryant , Yanli Wang

DOI: 10.1186/S13321-017-0200-8

关键词:

摘要: Drug–drug interactions (DDIs) may lead to adverse effects and potentially result in drug withdrawal from the market. Predicting DDIs during development would help reduce costs time by rigorous evaluation of candidates. The primary mechanisms are based on pharmacokinetics (PK) pharmacodynamics (PD). This study examines 2D structural similarities drugs DDI prediction through interaction networks including both PD PK knowledge. Our assumption was that a query (Dq) be examined (De) likely have if network De structurally similar Dq. A describes associations between proteins relating for De. These include target proteins, interacting with enzymes, transporters We constructed logistic regression models using only each Dq results indicated our could effectively predict DDIs. It found integrating similarity scores crucial model performance. In particular, combination target- enzyme-related provided largest increase predictive power. Graphical abstract .

参考文章(30)
Luca Gallelli, Chiara Giofrè, Antonio Siniscalchi, Caterina Palleria, Giovambattista De Sarro, Antonello Di Paolo, Giacomo Leuzzi, Chiara Caglioti, Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of Research in Medical Sciences. ,vol. 18, pp. 601- 610 ,(2013)
Jin Niu, Robert M Straubinger, Donald E Mager, Pharmacodynamic Drug–Drug Interactions Springer Berlin Heidelberg. pp. 367- 376 ,(2011) , 10.1007/978-3-540-89891-7_29
Ping Zhang, Fei Wang, Jianying Hu, Robert Sorrentino, Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects Scientific Reports. ,vol. 5, pp. 12339- 12339 ,(2015) , 10.1038/SREP12339
Juan M. Banda, Alison Callahan, Rainer Winnenburg, Howard R. Strasberg, Aurel Cami, Ben Y. Reis, Santiago Vilar, George Hripcsak, Michel Dumontier, Nigam Haresh Shah, Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records Drug Safety. ,vol. 39, pp. 45- 57 ,(2016) , 10.1007/S40264-015-0352-2
H. G. Mahesha, Sridevi Annapurna Singh, N. Srinivasan, A. G. Appu Rao, A spectroscopic study of the interaction of isoflavones with human serum albumin. FEBS Journal. ,vol. 273, pp. 451- 467 ,(2006) , 10.1111/J.1742-4658.2005.05071.X
Toshiyuki Sakaeda, Kohji Takara, Mikio Kakumoto, Nobuko Ohmoto, Tsutomu Nakamura, Koichi Iwaki, Yusuke Tanigawara, Katsuhiko Okumura, Simvastatin and lovastatin, but not pravastatin, interact with MDR1. Journal of Pharmacy and Pharmacology. ,vol. 54, pp. 419- 423 ,(2010) , 10.1211/0022357021778493
Lorenzo Di Bari, Silvia Ripoli, Sanghamitra Pradhan, Piero Salvadori, Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference. Chirality. ,vol. 22, pp. 593- 596 ,(2009) , 10.1002/CHIR.20794
Hui Huang, Ping Zhang, Xiaoyan A. Qu, Philippe Sanseau, Lun Yang, Systematic prediction of drug combinations based on clinical side-effects Scientific Reports. ,vol. 4, pp. 7160- 7160 ,(2015) , 10.1038/SREP07160
Ni Ai, Xiaohui Fan, Sean Ekins, In silico methods for predicting drug–drug interactions with cytochrome P-450s, transporters and beyond Advanced Drug Delivery Reviews. ,vol. 86, pp. 46- 60 ,(2015) , 10.1016/J.ADDR.2015.03.006